PARIDHI SHAH MD
Prescription History 1013478080
Psychiatry & Neurology - Neurology with Special Qualifications in Child Neurology in Ann Arbor, MI

Active since March 30, 2019PECOS EnrolledAccepts Medicare Assignment
1500 E MEDICAL CENTER DR, ANN ARBOR, MI 48109(734) 936-4000 Get Directions

NPPES record last updated: July 12, 2024. Verified against the NPPES registry weekly; last sync: October 18, 2026.

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for PARIDHI SHAH MD, an active Neurology with Special Qualifications in Child Neurology specialist practicing in Ann Arbor, MI. Our medical registry currently tracks 1 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 12 documented patient claims. Among these therapy options, the most frequently utilized medication is Kesimpta Pen, which accounts for 12 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

1
Medication
12
Total Claims
12
30-Day Fills
Kesimpta Pen
Most Prescribed · 12 claims
View details
1 medication · 2024 Medicare Part D
Medicare Part D medications prescribed by PARIDHI SHAH MD in 2024, with prescription volumes, average cost per fill, and MI state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other MI PrescribersVs. MI Avg
Kesimpta PenOfatumumab12$11,390.66▼ Less than typical

About Kesimpta Pen: This medication is used to treat multiple sclerosis (MS). Show more ▾

Ofatumumab belongs to a class of medications known as monoclonal antibodies. This medication is not a cure for MS but it is thought to help by preventing immune system cells (lymphocytes) from attacking the nerves in your brain and spinal cord. It helps decrease the number of episodes of disease worsening (relapses) and may prevent or delay disability. An anti-CD20 MAb used as an antineoplastic agent; in phase 1-2 clinical trials.

In 2024, this provider wrote 12 Medicare prescriptions for Kesimpta Pen, about a third of the volume of the typical Michigan prescriber of this medication (32.9). Medicare paid an average of $11,390.66 per fill, versus $9,424.21 statewide.

How often this provider prescribes it

This provider
12
MI average
32.9

This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$11,390.66
MI average
$9,424.21

Gross Part D cost per fill; not the patient's out-of-pocket price.

12
30-Day Fills
standardized to 30-day supplies
356
Days of Medication
total across all patients in 2024
No medications match the current filters.
▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average MI prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the MI average cost per fill.

About this data. The prescription history for PARIDHI SHAH MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Neurology with Special Qualifications in Child Neurology prescribing approach at this Ann Arbor, MI practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among MI prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.